{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:17:30Z","timestamp":1790813850778,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.neubiorev.2023.105166","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T02:57:45Z","timestamp":1681181865000},"page":"105166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington\u2019s disease"],"prefix":"10.1016","volume":"149","author":[{"given":"Melanie L.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Abimanyi-Ochom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Khanh-Dao Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2023.105166_bib1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1017\/S0033291720000094","article-title":"Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington\u2019s disease","volume":"51","author":"Andrews","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2023.105166_bib2","first-page":"10","article-title":"International guidelines for the treatment of Huntington\u2019s disease","author":"Bachoud-L\u00e9vi","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib3","unstructured":"Barendregt, J.J., Doi, S.A., 2016. MetaXL User Guide [WWW Document]. EpiGear Int. URL \u3008https:\/\/moam.info\/metaxl-user-guide-epigear-international_597ef5501723dd6de346b573.html\u3009 (accessed 1.22.22)."},{"key":"10.1016\/j.neubiorev.2023.105166_bib4","first-page":"1","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neubiorev.2023.105166_bib5","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.5110-12.2013","article-title":"Huntingtin mediates anxiety\/depression-related behaviors and hippocampal neurogenesis","volume":"33","author":"Ben M\u2019Barek","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105166_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2017-BNPA.33","article-title":"9 Is apathy a problem in huntington\u2019s disease? a systematic review of the evidence","volume":"88","author":"Black","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105166_bib7","doi-asserted-by":"crossref","unstructured":"Borenstein, M., Hedges, L.V., Higgins, J.P.T., Rothstein, H.R., 2009. Introduction to Meta\u2010Analysis. John Wiley & Sons, Ltd.","DOI":"10.1002\/9780470743386"},{"key":"10.1016\/j.neubiorev.2023.105166_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2288-11-41","article-title":"Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Qstatistics","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/mds.26208","article-title":"Apathy in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"30","author":"den Brok","year":"2015","journal-title":"Mov. Disord. . J. Mov. Disord. Soc."},{"key":"10.1016\/j.neubiorev.2023.105166_bib10","unstructured":"Clark, M.L., Abimanyi-Ochom, J., Le, L., Le, H., Long, B., Orr, C., n.d. A systematic review of the diagnosis and presentation of depression and apathy in Huntington\u2019s disease [WWW Document]. PROSPERO. URL \u3008https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=259572\u3009 (accessed 8.21.22)."},{"key":"10.1016\/j.neubiorev.2023.105166_bib11","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/s41386-018-0107-8","article-title":"Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington\u2019s disease","volume":"43","author":"Covey","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2023.105166_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JHD-180339","article-title":"Clinical presentation and features of juvenile-onset Huntington\u2019s disease: a systematic","volume":"8","author":"Cronin","year":"2019","journal-title":"Rev. J. Huntingt. Dis."},{"key":"10.1016\/j.neubiorev.2023.105166_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2023.105166_bib14","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1007\/s12035-018-0890-6","article-title":"Brain-derived neurotrophic factor prevents depressive-like behaviors in early-symptomatic YAC128 Huntington\u2019s disease mice","volume":"55","author":"da Fons\u00eaca","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11065-017-9356-2","article-title":"Imaging markers of post-stroke depression and apathy: a systematic review and meta-analysis","volume":"27","author":"Douven","year":"2017","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neubiorev.2023.105166_bib16","article-title":"Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington\u2019s disease","volume":"2","author":"Du","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105166_bib17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jpsychires.2013.05.026","article-title":"Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study","volume":"47","author":"Epping","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2023.105166_bib18","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.3390\/ijerph18189597","article-title":"The apathy evaluation scale (AES-C): psychometric properties and invariance of Italian version in mild cognitive impairment and Alzheimer\u2019s disease","volume":"18","author":"Furneri","year":"2021","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"10.1016\/j.neubiorev.2023.105166_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2016.01.019","article-title":"Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease","volume":"278","author":"Garcia-Miralles","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1176\/appi.neuropsych.19080181","article-title":"Assessing mental health difficulties of persons with Huntington\u2019s disease: does informant presence make a difference?","volume":"32","author":"Gunn","year":"2020","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105166_bib21","first-page":"10","article-title":"A touchscreen motivation assessment evaluated in Huntington\u2019s disease patients and R6\/1 model mice","author":"Heath","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mdc3.13178","article-title":"Sex differences in Huntington\u2019s disease: evaluating the Enroll\u2010HD database","volume":"8","author":"Hentosh","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.neubiorev.2023.105166_bib23","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1007\/s00415-018-9013-6","article-title":"Risk factors of suicidal ideation in Huntington\u2019s disease: literature review and data from Enroll-HD","volume":"265","author":"Honrath","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib24","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease","volume":"22","author":"Hult Lundh","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neubiorev.2023.105166_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jnnp.2006.103309","article-title":"Psychiatric disorders in preclinical Huntington\u2019s disease","volume":"78","author":"Julien","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105166_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11940-011-0140-y","article-title":"Treatment of apathy in Huntington\u2019s disease and other movement disorders","volume":"13","author":"Krishnamoorthy","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jad.2016.03.063","article-title":"Exercise as a treatment for depression: a meta-analysis","volume":"202","author":"Kvam","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2023.105166_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1099800418776082","article-title":"Biological sex differences in depression: a systematic review","volume":"20","author":"Labaka","year":"2018","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.neubiorev.2023.105166_bib29","first-page":"9","article-title":"Genetics modulate gray matter variation beyond disease burden in prodromal Huntington\u2019s disease","author":"Liu","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib30","doi-asserted-by":"crossref","unstructured":"Marin, R.S., Biedrzycki, R.C., Firinciogullari, S., 1991. Reliability and Validity of the Apathy Evaluation Scale 38, 143\u2013162.","DOI":"10.1016\/0165-1781(91)90040-V"},{"key":"10.1016\/j.neubiorev.2023.105166_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5334\/tohm.231","article-title":"The many facets of unawareness in Huntington disease","volume":"4","author":"McCusker","year":"2014","journal-title":"Tremor Hyperkinetic Mov."},{"key":"10.1016\/j.neubiorev.2023.105166_bib32","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/s41598-018-20607-7","article-title":"Early detection of apathetic phenotypes in Huntington\u2019s disease knock-in mice using open source tools","volume":"8","author":"Minnig","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2023.105166_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1017\/S1355617719000067","article-title":"Apathy is related to cognitive control and striatum volumes in prodromal Huntington\u2019s disease","volume":"25","author":"Misiura","year":"2019","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neubiorev.2023.105166_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neubiorev.2015.03.003","article-title":"Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington\u2019s disease","volume":"52","author":"Mo","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2023.105166_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1176\/jnp.2009.21.3.266","article-title":"Apathy is not depression in Huntington\u2019s disease","volume":"21","author":"Naarding","year":"2009","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105166_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","article-title":"Huntington\u2019s disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation","volume":"507","author":"Orvoen","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2023.105166_bib37","first-page":"4","article-title":"Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL\/6J mice during abstinence from chronic ethanol consumption","author":"Pang","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/brainsci7060067","article-title":"Neuropsychiatric burden in Huntington\u2019s disease","volume":"7","author":"Paoli","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.neubiorev.2023.105166_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","article-title":"Neuropsychiatric aspects of Huntington\u2019s disease","volume":"71","author":"Paulsen","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105166_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0364-7722(79)90056-0","article-title":"Reliability and validity studies of the comprehensive Psychopathological Rating Scale (CPRS)","volume":"3","author":"Perris","year":"1979","journal-title":"Prog. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00415-018-8940-6","article-title":"Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration","volume":"266","author":"Podvin","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib42","unstructured":"PRISMA, 2021. PRISMA: Transparent reporting of systematic reviews and meta-analyses [WWW Document]. URL \u3008http:\/\/www.prisma-statement.org\/PRISMAStatement\/FlowDiagram\u3009 (accessed 1.6.22)."},{"key":"10.1016\/j.neubiorev.2023.105166_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099320","article-title":"The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio\/chow feeding choice task: reversal with antidepressant drugs","volume":"9","author":"Randall","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2023.105166_bib44","doi-asserted-by":"crossref","first-page":"RRN1281","DOI":"10.1371\/currents.RRN1281","article-title":"Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice","volume":"3","author":"Renoir","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.neubiorev.2023.105166_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington\u2019s disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2023.105166_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2012.239798","article-title":"Differential effects of early environmental enrichment on emotionality related behaviours in Huntington\u2019s disease transgenic mice","volume":"591","author":"Renoir","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpsychires.2016.02.023","article-title":"Exercise as a treatment for depression: a meta-analysis adjusting for publication bias","volume":"77","author":"Schuch","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2023.105166_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.neuropsych.18120319","article-title":"A systematic review of neuropsychiatric symptoms and functional capacity in Huntington\u2019s disease","volume":"32","author":"Sellers","year":"2019","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105166_bib49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0447.1994.tb01587.x","article-title":"Psychopathology in Huntington\u2019s disease patients","volume":"90","author":"Shiwach","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neubiorev.2023.105166_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JHD-140109","article-title":"Unawareness of deficits in Huntington\u2019s disease","volume":"3","author":"Sitek","year":"2014","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.neubiorev.2023.105166_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000481981","article-title":"Apathy profile in Parkinson\u2019s and Huntington\u2019s disease: a comparative cross-sectional study","volume":"79","author":"Sousa","year":"2018","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2017.05.004","article-title":"Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG140 knock-in mouse model of Huntington\u2019s disease","volume":"105","author":"Stefanko","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2023.105166_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neubiorev.2023.105166_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/gps.1244","article-title":"The applicability and the inter-rater reliability of the Comprehensive Psychopathological Rating Scale in an elderly clinical population","volume":"20","author":"van der Laan","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105166_bib55","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY)","volume":"85","author":"van Duijn","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105166_bib56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1176\/jnp.2010.22.3.287","article-title":"Correlates of apathy in Huntington\u2019s disease","volume":"22","author":"van Duijn","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105166_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1176\/jnp.17.1.7","article-title":"Apathy: why care?","volume":"17","author":"van Reekum","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105166_bib58","unstructured":"WHO, 2021. Depression [WWW Document]. World Health Organ. URL \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression\u3009 (accessed 1.9.22)."},{"key":"10.1016\/j.neubiorev.2023.105166_bib59","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/ene.13889","article-title":"Longitudinal assessment of the Unified Huntington\u2019s Disease Rating Scale (UHDRS) and UHDRS\u2013For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington\u2019s disease","volume":"26","author":"Winder","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105166_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-3956(94)90036-1","article-title":"Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review","volume":"28","author":"Wittchen","year":"1994","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2023.105166_bib61","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/01616412.2016.1214555","article-title":"Clinical and genetic characteristics in patients with Huntington\u2019s disease from China","volume":"38","author":"Yang","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neubiorev.2023.105166_bib62","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","article-title":"The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion","volume":"232","author":"Yohn","year":"2015","journal-title":"Psychopharmacology"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:27:03Z","timestamp":1758968823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763423001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":62,"alternative-id":["S0149763423001355"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105166","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105166"}}